Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients

Benzer Materyaller

• Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia
  Yazar:: de Benito, Alvaro de Santiago, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia
  Yazar:: Bacher, Ulrike, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
  Yazar:: Bacher, Ulrike, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series
  Yazar:: Flach, Johanna, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia
  Yazar:: Seipel, Katja, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)